About Decitabine
Class: | Antineoplastic agent, Hypomethylating agent
Use: | Treatment of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
Adult dose: | 15 mg/m² IV over 3 hours on days 1-5 of a 28-day cycle; may be repeated for up to 6 cycles
Pediatric dose: | Safety and efficacy not established; use is not recommended
Side effects: | Nausea, vomiting, diarrhea, fatigue, fever, anemia, thrombocytopenia, leukopenia
Contraindications: | Hypersensitivity to decitabine or any component of
Drug Class
Antineoplastic agent, Hypomethylating agent
Uses & Indications
Treatment of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
Storage Requirements
Store at 20-25°C (68-77°F); protect from light; reconstituted solution should be used immediately or stored at 2-8°C for up to 24 hours
Manufacturer & Packaging
Manufacturer: Accord Healthcare Inc, U.S.A
Package Size
SINGLE DOSE VIAL
Price & Supplier
Price in UAE: AED 747.50
Dosage Information
Adult Dose
15 mg/m² IV over 3 hours on days 1-5 of a 28-day cycle; may be repeated for up to 6 cycles
Pediatric Dose
Safety and efficacy not established; use is not recommended
Side Effects
Nausea, vomiting, diarrhea, fatigue, fever, anemia, thrombocytopenia, leukopenia
Contraindications & Precautions
Hypersensitivity to decitabine or any component of the formulation; pregnancy; breastfeeding
Important Warnings
Risk of myelosuppression, infections, and bleeding; monitor blood counts regularly; potential for fetal harm; use caution in patients with renal or hepatic impairment
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.